RGDXQ OTC
Response Genetics, Inc
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -95.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$18M
+7.9% ▲
5Y CAGR: -3.2%
Gross Profit
$4M
-41.2% ▼
5Y CAGR: -18.3%
Operating Income
-$21M
-64.3% ▼
Net Income
-$20M
-49.1% ▼
EPS (Diluted)
$-0.52
-48.6% ▼
EBITDA
-$20M
-51.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 |
|---|---|---|---|---|---|
| Revenue | $23M | $19M | $20M | $17M | $18M |
| YoY Growth | +6.4% | -17.3% | +5.7% | -15.6% | +7.9% |
| Cost of Revenue | $12M | $10M | $10M | $10M | $14M |
| Gross Profit | $11M | $8M | $9M | $7M | $4M |
| Gross Margin | 48.2% | 44.4% | 47.2% | 40.1% | 21.9% |
| R&D Expenses | $1M | $2M | $2M | $2M | $5M |
| SG&A Expenses | $15M | $14M | $16M | $18M | $20M |
| Operating Expenses | $17M | $16M | $17M | $20M | $25M |
| Operating Income | -$6M | -$8M | -$8M | -$13M | -$21M |
| Operating Margin | -25.1% | -40.9% | -40.1% | -77.8% | -118.5% |
| Interest Expense | $21K | $86K | $92K | $665K | $344K |
| Income Before Tax | -$6M | -$8M | -$8M | -$14M | -$21M |
| Tax Expense | $21K | -$384K | -$541K | -$163K | -$1M |
| Net Income | -$6M | -$7M | -$7M | -$14M | -$20M |
| Net Margin | -25.3% | -39.3% | -37.8% | -81.0% | -111.9% |
| EPS (Diluted) | $-0.30 | $-0.28 | $-0.22 | $-0.35 | $-0.52 |
| EBITDA | -$5M | -$7M | -$8M | -$13M | -$20M |
| Shares Outstanding | 19M | 27M | 33M | 39M | 39M |